Stay up to date with what our teams are doing day-to-day working for The Common Good.
More than 500 clinicians at over 370 hospitals worldwide sign up to use a new IBM app that will securely share information to care for COVID-19 patients
Clinicians and Researchers from The Prince Charles Hospital have developed whole lung lavage, a ground-breaking new treatment that provides a glimmer of hope to those suffering with artificial stone silicosis, a deadly lung disease.
10 new medical research projects are putting the money raised from the successful 2020 Ekka Strawberry Sundaes campaign to immediate use.
Annalicia is now performing a clinical trial to see if dietary fibre can reduce inflammation in lung cells through healthy gut bacteria.
Thousands of people every year find themselves in Intensive Care suffering a life-threatening illness - and many will experience collapsed lungs. There is no definitive way to best restore the lungs after collapse - sometimes it's done using a ventilator, other times they are manually inflated.
Advance our lifesaving research into silicosis. This is unprecedented. We’ve launched an Emergency Silicosis Appeal because we need your help to tackle an escalating health crisis.
Dr James Anderson, a Sleep Fellow at The Prince Charles Hospital, wants to make sure that these most vulnerable people in our community are receiving the care they need.
Dr Chambers and his team in the thoracic lab at The Prince Charles Hospital are looking for the first key in effectively treating IPF.
The success of this project will lead to improved quality of care and reduced side effects for people with CADs, as well as reduce the number of people who fall seriously ill or die from these debilitating diseases.